Guglielmi Francesco William, Regano Nunzia, Mazzuoli Silvia, Rizzi Massimiliano, Fregnan Simona, Leogrande Giuseppina, Addante Irene, Guglielmi Altomarino
Department of Gastroenterology & Artificial Nutrition, "San Nicola Pellegrino" Hospital - Trani (BT) - Italy.
J Vasc Access. 2012 Oct-Dec;13(4):490-7. doi: 10.5301/jva.5000133.
Home Parenteral Nutrition is a therapeutic option to improve quality of life in chronic intestinal failure.
To describe frequency of complications both in cancer and noncancer patients.
This study was performed on 270 adult patients (52% with cancer, 48% without cancer) followed for a total of 371 years of treatment. Mean duration of therapy was 191±181 for cancer and 830±1168 days/patient for noncancer. The treatment was administered by a competent, dedicated provider. Patients received our prescribed "all-in-one admixtures" at their homes.
Catheter-related complications/1000-days-catheter was 1.40; mechanical complications were comparable in cancer (0.82) and noncancer (0.91) patients while a statistically significant difference was observed between cancer (0.71) and noncancer (0.46) patients for sepsis. Bacterial infections were more frequent in noncancer, mycotic infections primarily affected cancer patients. In our experience 49% of the patients were readmitted, with a low incidence rate of 0.89/1000 days-catheter. The incidence of hepatobiliary complications in our population was 65%. The degree of liver damage was related to short bowel syndrome and to length of treatment.
This study indicated that cancer patients are more vulnerable to CVC-related infections during Home Parenteral Nutrition and that a safer Home Parenteral Nutrition protocol should be adopted in order to contain CVC-related complications.
家庭肠外营养是改善慢性肠衰竭患者生活质量的一种治疗选择。
描述癌症患者和非癌症患者并发症的发生频率。
本研究对270例成年患者进行(52%为癌症患者,48%为非癌症患者),总共随访了371年的治疗时间。癌症患者的平均治疗时长为191±181天,非癌症患者为830±1168天/患者。治疗由专业、专注的医护人员进行。患者在家中接受我们规定的“全合一混合液”。
每1000天导管相关并发症发生率为1.40;机械性并发症在癌症患者(0.82)和非癌症患者(0.91)中相当,而在脓毒症方面,癌症患者(0.71)和非癌症患者(0.46)之间观察到统计学上的显著差异。细菌感染在非癌症患者中更常见,真菌感染主要影响癌症患者。根据我们的经验,49%的患者再次入院,每1000天导管发生率为0.89。我们研究人群中肝胆并发症的发生率为65%。肝损伤程度与短肠综合征和治疗时长有关。
本研究表明,癌症患者在家庭肠外营养期间更容易发生中心静脉导管相关感染,应采用更安全的家庭肠外营养方案以控制中心静脉导管相关并发症。